Composite dietary fiber alleviates obesity-induced skeletal muscle atrophy by regulating gut microbiota-derived short-chain fatty acids in mice

Yutong Xie, Dazhang Deng, Shan Wang, Zhixin Li, Tingyi Mo, Ya Wang, Honghui GuoNpj 2026 · DOI

This study, published in npj Science of Food, explores the "gut-muscle axis" to find a nutritional solution for a growing public health crisis: obesity-induced muscle wasting. Researchers found that a specific blend of dietary fibers can effectively "turn off" the molecular machinery that degrades muscle tissue in obese mice by rebalancing their gut microbiome and boosting the production of beneficial metabolites like butyrate.

TL;DR

Composite dietary fiber (CDF) acts as a metabolic shield, preventing obesity-linked muscle atrophy in mice by modulating the gut-muscle axis. By enriching short-chain fatty acid (SCFA)-producing bacteria, the fiber intervention significantly boosts butyrate levels, which in turn inhibits the proteolytic pathways responsible for breaking down muscle protein.

What Problem Does This Paper Address?

Obesity is often viewed through the lens of adipose (fat) accumulation, but it frequently triggers a secondary, more insidious condition: skeletal muscle atrophy. This "sarcopenic obesity" creates a dangerous feedback loop where muscle loss reduces metabolic rate and physical activity, further exacerbating obesity and increasing the risk of type 2 diabetes and cardiovascular disease.

While isolated fibers (like inulin or cellulose) have been studied individually, human diets are complex. The authors address the gap in understanding how a composite formulation of diverse fibers—mimicking a more varied diet—interacts with the gut microbiota to protect muscle health. They specifically look at the Ubiquitin-Proteasome System (UPS), the body’s primary "protein shredder," which becomes overactive during obesity.

Methods

The researchers used a C57BL/6 mouse model, inducing obesity via a High-Fat Diet (HFD) for 24 weeks. They then introduced an 8-week intervention where one group received the HFD supplemented with 5% Composite Dietary Fiber (CDF).

The CDF formulation was notably diverse, containing: * Prebiotics: Resistant starch, dextrin, FOS, and oat $\beta$-glucan. * Natural Extracts: L-arabinose and blueberry anthocyanins. * Botanical/Medicinal Foods: Bitter gourd, white kidney bean, mulberry leaf, and roselle.

To evaluate the effects, the team employed a multi-disciplinary toolkit:

  • Physiological Testing: Grip strength and rotarod endurance (motor coordination).
  • Molecular Biology: Western blotting and RT-qPCR to track muscle-wasting markers like Atrogin-1 and MuRF-1.
  • Omics: 16S rRNA sequencing for gut microbiota profiling and Gas Chromatography-Mass Spectrometry (GC-MS) to quantify SCFAs in the colon and serum.

Datasets

As a biological study, the primary "datasets" generated were the microbial and metabolic profiles of the experimental groups:

  • Control (CON): Standard chow.
  • Obese (HFD): 60% kcal from fat.
  • Intervention (HFD+DF): HFD plus the composite fiber blend.
  • Microbial Data: Operational Taxonomic Units (OTUs) and functional predictions via PICRUSt2, which estimates the metabolic capabilities of the bacteria present.

Key Insights and Ideas

  • Weight Loss Without Calorie Cutting: Mice on the CDF intervention lost significant weight (~3g) and fat mass despite consuming the same number of calories as the HFD group. This suggests the fiber improved energy expenditure or reduced fat absorption rather than just acting as a filler.
  • The Butyrate "Aha" Moment: The most striking metabolic change was a 123.8% increase in colonic butyric acid. Butyrate isn't just fuel for gut cells; it acts as a signaling molecule that enters the bloodstream and tells muscles to stop breaking down protein.
  • Silencing the "Shredders": Obesity normally upregulates Atrogin-1 and MuRF-1—enzymes that tag muscle proteins for destruction. The CDF intervention significantly downregulated these proteins, effectively putting the brakes on muscle wasting at the molecular level.
  • Microbial Rebalancing: The fiber shifted the gut from a "pro-obesity" state (high Firmicutes to Bacteroidota ratio) to a healthier profile, specifically enriching Bifidobacterium and Lactobacillus.

Key Results

  • Physical Performance: CDF-treated mice saw a 52.2% increase in forelimb grip strength and a staggering 256.9% improvement in rotarod endurance compared to the obese group.
  • Muscle Morphology: The cross-sectional area (CSA) of muscle fibers increased by 10.6% to 14.7%, indicating a reversal of the "shrinking" effect of obesity.
  • Metabolic Health: Total cholesterol (TC) and LDL-C dropped by 25.3% and 53.5%, respectively, while insulin resistance (HOMA-IR) was significantly ameliorated.
  • Oxidative Stress: The intervention restored antioxidant enzyme activities (GPx) and reduced malondialdehyde (MDA), a marker of cellular damage, by 25.6%.

Limitations and Future Work

  • Gender Bias: The study was conducted exclusively on male mice. Hormonal differences mean these results may not translate identically to females.
  • Causality vs. Correlation: While the correlation between increased Bifidobacterium, higher butyrate, and better muscle mass is strong, the authors note that Fecal Microbiota Transplantation (FMT) into germ-free mice is needed to prove that the bacteria themselves are the cause of the muscle improvement.
  • Component Synergy: Because the fiber was a "composite," it is unclear which specific ingredient (e.g., the bitter gourd vs. the resistant starch) provided the most benefit, or if the synergy of the blend is strictly necessary.

In conclusion, this paper provides a compelling blueprint for using complex dietary fibers as a therapeutic tool to manage the muscular complications of obesity, highlighting the gut as a central regulator of physical strength.

Summary updated

Abstract

Obesity-induced muscle atrophy is a major health issue, in which gut microbiota play a key role in regulating metabolism and muscle health. This study investigated how composite dietary fiber protects against muscle atrophy in mice fed a high-fat diet (HFD). After 24 weeks of obesity induction, mice were divided into two groups: one continued on the HFD, while the other received the HFD supplemented with composite dietary fiber for 8 weeks. Composite dietary fiber ameliorated HFD-induced metabolic dysregulation by reducing adipose accumulation and improving insulin resistance. Notably, composite dietary fiber preserved skeletal muscle mass and function and downregulated the expression of key proteolytic markers Atrogin-1 and MuRF-1. The intervention enriched beneficial gut microbiota, particularly Bifidobacterium and other short-chain fatty acid (SCFA)-producing taxa, and elevated SCFA levels in both the colon and serum, with butyric acid increasing by 123.8% and 19.4%, respectively. PICRUSt2 analysis demonstrated enhanced microbial pyruvate and butanoate metabolism pathways, and correlation analyses revealed close relationships among microbiota, SCFAs, and muscle parameters. Collectively, these data suggest a potential mechanism whereby composite dietary fiber counteracts muscle atrophy in obesity by modulating the gut microbiota to increase SCFA production and downregulate proteolytic signaling, implicating its potential as a dietary intervention for muscle metabolic disorders.
BibTeX
@inproceedings{xie2026composite,
  author = {Yutong Xie and Dazhang Deng and Shan Wang and Zhixin Li and Tingyi Mo and Ya Wang and Honghui Guo},
  title = {{Composite dietary fiber alleviates obesity-induced skeletal muscle atrophy by regulating gut microbiota-derived short-chain fatty acids in mice}},
  booktitle = {Npj},
  year = {2026},
  doi = {10.1038/s41538-025-00698-z},
}
Figure